<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02306083</url>
  </required_header>
  <id_info>
    <org_study_id>92182</org_study_id>
    <nct_id>NCT02306083</nct_id>
  </id_info>
  <brief_title>Effect of Glucosamine on Intraocular Pressure</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this double blind clinical trial 92 patients suffering from rheumatoid arthritis are
      included. Those with the history of intraocular and corneal surgery, diabetic and heavy
      smokers are excluded from the study. Before starting the treatment all patients undergo
      complete ophthalmic exam, corneal biomechanical properties assessment by Ocular Response
      Analyzer (ORA) and corneal thickness measurement. Patients are randomly assigned to treatment
      and placebo groups. Those in the treatment groups receive glucosamine sulfate 1500 mg three
      times a day. Those in placebo arm receive alike capsule with the same schedule. At month 3
      and 6 IOP(intraocular pressure), ORA and pachymetry would be checked again.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2014</start_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraocular pressure changes</measure>
    <time_frame>until 6 months</time_frame>
    <description>: Goldmann applanation tonometry</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>corneal biomechanical changes</measure>
    <time_frame>until 6 months</time_frame>
    <description>Ocular Response Analyzer (ORA)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">41</enrollment>
  <condition>Intraocular Pressure Changes After Glucosamine Sulfate Consumption.</condition>
  <arm_group>
    <arm_group_label>Administration of the Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo three times a day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Administration of the glucosamine sulfate</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>glucosamine sulfate 1500 mg three times a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo three times a day</intervention_name>
    <arm_group_label>Administration of the Placebo</arm_group_label>
    <other_name>oral consumption</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>glucosamine sulfate 1500 mg three times a day</intervention_name>
    <arm_group_label>Administration of the glucosamine sulfate</arm_group_label>
    <other_name>oral consumption</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  History of rheumatoid arthritis based on ACR (American College of
             Rheumatology)FC(functional classes).

          -  No history of using drugs tested in the study.

        Exclusion Criteria:

          -  History of any kind of corneal surgery.

          -  History of intraocular surgery.

          -  History of diabetes mellitus.

          -  Heavy smokers.

          -  Unwillingness to participate in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mohammad Pakravan, MD</last_name>
    <phone>009822591616</phone>
    <email>labbafi@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Islamic Republic OF Iran</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammad Pakravan, MD</last_name>
      <phone>009822591616</phone>
      <email>labbafi@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2014</study_first_submitted>
  <study_first_submitted_qc>November 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2014</study_first_posted>
  <last_update_submitted>May 7, 2015</last_update_submitted>
  <last_update_submitted_qc>May 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shahid Beheshti University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Zahra Rabbani Khah</investigator_full_name>
    <investigator_title>clinical professor ,ophthalmic research center</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

